Our Pricing

Mounjaro Weight Loss Injection - In Stock UK

Published on: June 03, 2026

Finding mounjaro weight loss injection in stock uk can be challenging during periods of high demand. At Cured Pharmacy, we maintain consistent stock levels of genuine UK-licensed Mounjaro (tirzepatide) KwikPens with transparent pricing from £124.99 free clinical consultation by UK prescribers, and discreet next-day delivery across the UK.

How Mounjaro Weight Loss Injection Works

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURPASS-3 clinical trial, patients receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than comparator treatments [1]. The dual-agonist mechanism also demonstrated superior glycaemic control and cardiovascular risk factor improvements compared to single GLP-1 receptor agonists [2].

Mounjaro works by slowing gastric emptying, reducing appetite signals in the hypothalamus, and improving insulin sensitivity in peripheral tissues. Most patients report noticeable appetite reduction within the first two weeks of treatment, with progressive weight loss continuing throughout the titration schedule [3].

Mounjaro Dosing Schedule and What to Expect

During the initial titration phase, mild to moderate gastrointestinal symptoms — including nausea, diarrhoea, and reduced appetite — are common but typically resolve within 2-4 weeks as the body adjusts [3]. Your UK prescriber will monitor your progress and may adjust the escalation schedule if side effects persist.

Clinical trials demonstrated that patients who reached the higher maintenance doses (12.5mg or 15mg) experienced the greatest weight loss outcomes, though individual response varies based on baseline BMI, adherence to lifestyle modifications, and metabolic factors [1][2].

Standard Titration Protocol

UK prescribers typically initiate Mounjaro at 2.5mg once weekly for four weeks to minimise gastrointestinal side effects. The dose is then increased to 5mg weekly, with further escalations to 7.5mg, 10mg, 12.5mg, and finally 15mg at four-week intervals, subject to individual tolerability and clinical response [1].

Each KwikPen contains four pre-filled doses, and injections are self-administered subcutaneously in the abdomen, thigh, or upper arm. The once-weekly schedule offers significant convenience compared to daily injectable treatments, and the medication can be taken with or without food on the same day each week.

Mounjaro vs Wegovy: Comparing Weight Loss Injections

Both Mounjaro and Wegovy are once-weekly injectable treatments licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity. Your UK prescriber will assess your medical history, current medications, and treatment goals to determine which option is most appropriate.

At Cured Pharmacy, we stock both Mounjaro and Wegovy with transparent upfront pricing. Our clinical team can discuss the advantages and considerations of each treatment during your free online consultation, ensuring you receive the most suitable prescription for your individual circumstances.

Clinical Efficacy Differences

Head-to-head data from the SURPASS-2 trial showed tirzepatide produced superior weight loss compared to semaglutide 1mg (the active ingredient in Wegovy at a lower dose). At 40 weeks, patients on tirzepatide 15mg lost an average of 12.4kg compared to 6.2kg with semaglutide 1mg [2].

While both medications belong to the incretin class, Mounjaro's dual-receptor mechanism appears to offer enhanced metabolic benefits, particularly for patients with type 2 diabetes or significant insulin resistance. However, individual response varies, and some patients may experience better tolerability with single-agonist treatments.

Mounjaro Price UK: Transparent Pharmacy Costs

At Cured Pharmacy, Mounjaro weight loss injections start from £124.99 for genuine UK-licensed KwikPens. Unlike some providers, we display pricing upfront before you begin your consultation, with no hidden dispensing fees or subscription lock-ins.

The final cost depends on your prescribed dose, which your UK prescriber determines based on your clinical assessment and titration schedule. Each KwikPen contains four weekly doses, and we offer competitive pricing across all maintenance strengths to support long-term treatment adherence.

As a UK-registered pharmacy (GPhC 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we guarantee the lowest prices in the UK for genuine MHRA-licensed medications. All treatments are dispensed from our UK facility with discreet packaging and next-day delivery options available.

Who Can Use Mounjaro Weight Loss Injection in the UK

During your free online consultation at Cured Pharmacy, a UK-registered prescriber will review your medical history, current medications, and weight management goals to determine if Mounjaro is clinically appropriate. The assessment typically takes under three minutes and includes screening for contraindications and potential drug interactions.

All prescription medications dispensed by Cured Pharmacy require clinical approval by a UK prescriber in accordance with MHRA regulations and GPhC standards. Our clinical team is available by phone on (+44) 116 4646009 if you have questions about your suitability for treatment before starting your consultation.

Eligibility Criteria

Mounjaro is licensed in the UK for adults aged 18 and over with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [4].

The medication is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic ketoacidosis. Pregnant or breastfeeding women should not use Mounjaro, and effective contraception is recommended during treatment [4].

How to Order Mounjaro Weight Loss Injection In Stock UK

At Cured Pharmacy, we maintain consistent stock levels of Mounjaro across all dosing strengths to minimise treatment interruptions during your weight loss journey. Our pharmacy team monitors supply chains closely and prioritises existing patients to ensure continuity of care.

Once your first prescription is fulfilled, our clinical team can arrange follow-up consultations to monitor your progress, adjust dosing as needed, and provide ongoing support. We offer flexible repeat prescription services with reminder notifications to help you maintain consistent treatment without gaps.

Simple Three-Step Process

Start by completing our free online medical consultation, which takes under three minutes. You'll answer questions about your weight history, current health conditions, medications, and treatment goals. Our UK-registered prescribers review every consultation individually to ensure clinical safety and appropriateness.

If Mounjaro is deemed suitable, your prescription is issued electronically and sent directly to our dispensing team. We prepare your order using genuine UK-licensed medication in discreet, unmarked packaging. Next-day delivery is available across the UK, with tracking provided for all orders.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Dahl, D., Onishi, Y., Norwood, P., Huh, R., Bray, R., Patel, H., & Rodríguez, Á. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/14689 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro is a prescription-only medication licensed by the MHRA for chronic weight management in eligible adults. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment and lifestyle modifications.